生物标志物 生物标志物
1Brigham Young University, Provo, UT, USA; Resonant, Heber City, UT, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
一种新的纳米孔测序方法可以准确地检测血液中的神经元衍生的无细胞DNA (cfDNA),显示阿尔茨海默病 (AD),帕金森病 (PD) 和肌缩侧面硬化症 (ALS) 的高水平. 这为诊断神经退行性疾病提供了一个有希望的,最少侵入性的工具.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 目前阿尔茨海默病 (AD) 生物标志物在早期查和广泛的神经退行性适用性方面是有限的.
- 初步发现表明,皮质神经元衍生的无细胞DNA (cfDNA) 在血液中与轻度认知障碍 (MCI) 和AD相关.
- 以前的cfDNA检测方法受到DNA损伤和有限范围的限制.
研究的目的:
- 开发和验证一种纳米孔测序方法,用于敏感,准确的神经元特异cfDNA分析.
- 评估cfDNA作为神经退行性疾病的生物标记物的潜力,包括AD,帕金森病 (PD) 和肌缩侧面硬化症 (ALS).
主要方法:
- 从血和各种神经元类型 (皮质,脊柱运动,多巴胺作用) 中提取DNA.
- 使用纳米孔技术进行全基因组测序,用于本地DNA甲基化分析.
- 在患者队列 (MCI/AD,PD,ALS) 和对照中确定了神经元特定的甲基化特征,并分析了cfDNA.
主要成果:
- 纳米孔测序在分配神经元类型方面实现了>96%的准确性.
- 与对照组相比,在患有MCI/AD,PD和ALS的患者中观察到显著升高的cfDNA水平.
- 分析了成千上万个特定于细胞类型的基位,证明了卓越的灵敏度和准确性.
结论:
- 纳米孔测序使得精确的神经元特异cfDNA甲基化分析.
- 这种方法显示出作为一种微创生物标志物的潜力,用于早期检测,分期和监测神经退行性疾病.
- 目前正在进行一项大型纵向AD验证研究.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516